Status:
UNKNOWN
Human Gut Microbiota and microRNA Expression
Lead Sponsor:
Xijing Hospital
Conditions:
Gut Microbiota
microRNA
Eligibility:
All Genders
18-30 years
Phase:
NA
Brief Summary
In this study, stachyose was used as an intervention factor. We will evaluate changes in fecal gut microbiota and miRNA expression profiles in subjects under stachyose intervention
Detailed Description
In the stachyose intervention group, each person in the stachyose intervention group took 5 g of stachyose daily before breakfast, and the administration method was 100 ml of drinking water dissolved ...
Eligibility Criteria
Inclusion
- healthy human
Exclusion
- people who need intake antibiotics，probiotics or its product
Key Trial Info
Start Date :
May 25 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2022
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT05392348
Start Date
May 25 2022
End Date
June 30 2022
Last Update
May 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
the First Affiliate Hospital of the Air Force Medical University
Xi'an, Shaanxi, China, 710062